Lung Cancer Europe: Tackling Lung Cancer misperceptions
Date
Address
Event Location
Event Description
Recommendations from patients and experts on lung cancer misperception
Lung Cancer is the most deadly cancer of the big four: more people die for lung cancer than of colon, breast and prostate cancer together. Yet, it receives considerably less attention than the other large cancer.
You are invited to a stakeholder discussion on lung cancer, the most deadly and silent type of cancer, on lung cancer patient and misperceptions at the European Parliament on the 18th of November.
- Prof Jesper Holst Petersen, MD, DMSc Consultant in Thoracic Surgery, Department of Cardiothoracic Surgery, Rigshospitalet, Denmark
- Prof Silvia Novello, Assistant Professor in the Thoracic Oncology Unit at San Luigi Hospital in Orbassano, Italy
- Prof Harry Groen, University of Groningen, University Medical Center Groningen (UMCG), Netherlands
LuCE is participating in a research on lung cancer and this stakeholder discussion will provide the opportunity to give input to the interim results.
This offers an important opportunity to discuss how Member States – and the European Union as a whole – are approaching the major public health challenge of cancer (lung cancer) as a chronic disease and future actions.
To register, please send an email to:
valeria.botta@edelman.com
Events of the week
Jobs
EURACTIV News
- Ambitious EU seeks to improve Middle Corridor trade route, secure position in Central Asia [Advocacy Lab Content]
- European Health Data Space can help create Ireland’s fit-for-purpose health system [Advocacy Lab Content]
- Irish pharma sector quizzes European election candidates on innovation, sustainability, and regulation [Advocacy Lab Content]
- Why the EU benchmarking on the rule of law needs to be revised
- EU too slow in getting back misspent funds, Court of Auditors warns